Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate-resistant polycystic ovary syndrome

Fertility and Sterility

Volumn 88, Issue 2, 2007, Pages 418-424

  Verit, Fatma Ferda ^a   Erel, Ozcan ^a   Kocyigit, Abdurrahim ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

anovulation; clomiphene citrate; Polycystic ovary syndrome; total antioxidant capacity

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANOVULATION; ANTIOXIDANT ACTIVITY; ARTICLE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; INSULIN SENSITIVITY; LONGITUDINAL STUDY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

ADULT; ANOVULATION; ANTIOXIDANTS; BODY MASS INDEX; CLOMIPHENE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; LONGITUDINAL STUDIES; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TREATMENT FAILURE;

EID: 34547685887     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.172     Document Type: Article

References (51)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
2. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
3. Dunaif A., and Finegood D.T. ß-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81 (1996) 942-947
4. Park K.H., Kim J.Y., Ahn C.W., Song Y.D., Lim S.K., and Lee H.C. Polycystic ovarian syndrome (PCOS) and insulin resistance. Int J Gynaecol Obstet 74 (2001) 261-267
5. Grulet H., Hecart A.C., Delemer B., Gross A., Sulmont V., Leutenegger M., et al. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol 38 (1993) 621-626 (Oxf)
6. Morales A.J., Laughlin G.A., Butzow T., Maheshwari H., Baumann G., and Yen S.S.C. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 81 (1996) 2854-2864
7. Acien P., Quereda F., Matallin P., Villarroya E., Lopez-Fernandez J.A., Acien M., et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 72 (1999) 32-40
8. Dale P.O., Tanbo T., Vaaler S., and Abyholm T. Body weight, hyperinsulinemia,and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 58 (1992) 487-491
9. Nestler J.E., and Jakubowicz D.J. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 82 (1997) 4075-4079
10. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83 (1998) 2361-2365
11. Lobo R.A., Gysler M., March C.M., Goebelsmann U., and Mishell Jr. D.R. Clinical and laboratory predictors of clomiphene response. Fertil Steril 37 (1982) 168-174
12. Polson D.W., Kiddy D.S., Mason H.D., and Franks S. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders. Fertil Steril 51 (1989) 30-34
13. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84 (1999) 1617-1622
14. Kurabayashi T., Suzuki M., Fujita K., Murakawa H., Hasegawa I., and Tanaka K. Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 126 (2006) 201-205
15. Garcia-Pardo L., Granados M.D., Gaytan F., Padilla C.A., Martinez-Galisteo E., Morales C., et al. Immunolocalization of glutaredoxin in the human corpus luteum. Mol Hum Reprod 5 (1999) 914-919
16. Agarwal A., Gupta S., and Sharma R.K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3 (2005) 28
17. Suzuki T., Sugino N., Fukaya T., Sugiyama S., Uda T., Takaya R., et al. Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril 72 (1999) 720-726
18. Sasaki J., Sato E.F., Nomura T., Mori H., Watanabe S., Kanda S., et al. Detection of manganese superoxide dismutase mRNA in the theca interna cells of rat ovary during the ovulatory process by in situ hybridization. Histochemistry 102 (1994) 173-176
19. Tarin J.J., Brines J., and Cano A. Antioxidants may protect against infertility. Hum Reprod 13 (1998) 1415-1416
20. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
21. Ferriman D., and Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21 (1961) 1440-1447
22. Dumesic D.A., Abbott D.H., Eisner J.R., Herrmann R.R., Reed J.E., Welch T.J., et al. Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. Fertil Steril 70 (1998) 94-101
23. Baillargeon J.P., Jakubowicz D.J., Iuorno M.J., Jakubowicz S., and Nestler J.E. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 82 (2004) 893-902
24. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
25. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
26. Nestler J.E., Stovall D., Akhter N., Iuorno M.J., and Jakubowicz M.J. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77 (2002) 209-215
27. Expert Committee on the Diagnosis and Classification. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
28. Comim F.V., and Spritzer P.M. Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome. Fertil Steril 81 (2004) 108-113
29. Laffer C.L., Laniado-Schwartzman M., Nasjletti A., and Elijovich F. 20-HETE and circulating insulin in essential hypertension with obesity. Hypertension 43 (2004) 388-392
30. Tiffany T.O., Watsky M.B., Burtis C.A., and Thacker L.H. Fluorometric fast analyzer: some applications to fluorescence measurements in clinical chemistry. Clin Chem 19 (1973) 871-882
31. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
32. World Health Organization. Manual for the standardized investigation and diagnosis of the infertile couple (1993), Cambridge University Press, Cambridge, United Kingdom
33. Robert Y., Dubrulle F., Gaillandre L., Ardaens Y., Thomas-Desrousseaux P., Lemaitre L., et al. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 64 (1995) 307-312
34. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37 (2004) 277-285
35. Aycicek A., Erel O., and Kocyigit A. Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr 164 (2005) 775-778
36. Demirbag R., Yilmaz R., Erel O., Gultekin U., Asci D., and Elbasan Z. The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 21 (2005) 851-855
37. Imani B., Eijkemans M.J., de Jong F.H., Payne N.N., Bouchard P., Giudice L.C., et al. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 85 (2000) 676-682
38. Cataldo N.A., Dumesic D.A., Goldsmith P.C., and Jaffe R.B. Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis. Hum Reprod 15 (2000) 1889-1897
39. Tsai-Turton M., and Luderer U. Opposing effects of glutathione depletion and follicle-stimulating hormone on reactive oxygen species and apoptosis in cultured preovulatory rat follicles. Endocrinology 147 (2006) 1224-1236
40. Eppig J.J., Hosoe M., O'Brien M.J., Pendola F.M., Requena A., and Watanabe S. Conditions that affect acquisition of developmental competence by mouse oocytes in vitro: FSH, insulin, glucose and ascorbic acid. Mol Cell Endocrinol 163 (2000) 109-116
41. Murray A.A., Molinek M.D., Baker S.J., Kojima F.N., Smith M.F., Hillier S.G., et al. Role of ascorbic acid in promoting follicle integrity and survival in intact mouse ovarian follicles in vitro. Reproduction 121 (2001) 89-96
42. Thomas F.H., Leask R., Srsen V., Riley S.C., Spears N., and Telfer E.E. Effect of ascorbic acid on health and morphology of bovine preantral follicles during long-term culture. Reproduction 122 (2001) 487-495
43. Otala M., Erkkilä K., Tuuri T., Sjöberg J., Suomalainen L., Suikkari A.M., et al. Cell death and its suppression in human ovarian tissue culture. Mol Hum Reprod 8 (2002) 228-236
44. Kyei-Mensah A.A., LinTan S., Zaidi J., and Jacobs H.S. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum Reprod 13 (1998) 1437-1441
45. Puzigaca Z., Prelevic G.M., Stretenovic Z., and Balint-Peric L. Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol Endocrinol 5 (1991) 167-174
46. Dumesic D.A., Damario M.A., Session D.R., Famuyide A., Lesnick T.G., Thornhill A.R., et al. Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization. J Clin Endocrinol Metab 86 (2001) 2538-2543
47. Vendola K.A., Zhou J., Adesanya O.O., Weil S.J., and Bondy C.A. Androgens stimulate early stages of follicle growth in the primate ovarian. J Clin Invest 101 (1998) 2622-2629
48. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev 38 (2006) 171-196
49. Behrman H.R., Preston S.L., Aten R.F., Rinaudo P., and Zreik T.G. Hormone induction of ascorbic acid transport in immature granulosa cells. Endocrinology 137 (1996) 4316-4321
50. Miller J.K., Brzezinska-Slebodzinska E., and Madsen F.C. Oxidative stress, antioxidants, and animal function. J Dairy Sci 76 (1993) 2812-2823
51. LaPolt P.S., and Hong L.S. Inhibitory effects of superoxide dismutase and cyclic guanosine 3′,5′-monophosphate on estrogen production in cultured rat granulosa cells. Endocrinology 136 (1995) 5533-5539